EastBridge Partners

EastBridge Partners is an independent private equity firm based in Seoul, South Korea, established in 2011. It focuses on mid-market growth capital investment opportunities primarily in Korea, Greater China, and Japan. The firm targets various sectors, including technology, machinery, automotive and shipbuilding components, alternative energy, and retail. EastBridge Partners aims to create long-term value in its portfolio companies by enhancing their business and operational development.

Jie Ren Chang

Principal

Dongsuk Choi

CEO and Managing Partner

Yoon Seok Chung

Managing Director

Sung Hong

Co-Founding Partner

Jaemin Hwang

Operations Partner

Yewhan Jeong

Principal

Mark Kim

Chief Investment Officer, Singapore

Hyeongjin Ko

Principal

Sooho Lee

Principal

Kevin Jung Gang Lim

Co-Founder, Managing Partner and Chairman

Jisoo Park

Chief Investment Officer and Partner

Eunjoon Park

Managing Director

Yeonjeong Suh

Director

Sangchul Han Ph.D

Operations Partner

11 past transactions

USM Healthcare

Private Equity Round in 2022
USM Healthcare Medical Devices Factory JSC is the leading healthcare manufacturer in Vietnam. USM Healthcare factory is well equipped with facilities to meet high-tech production requirements including production workshops, microbiology and quality control rooms, testing rooms, materials, and packing warehouses.

Socar Malaysia

Series B in 2021
Socar Mobility Malaysia Sdn. Bhd., through an application, provides car rental services in Malaysia. The company is based in Malaysia.

Tmap Mobility

Private Equity Round in 2021
T-Map Mobility is a navigation service provider.

YIDO

Venture Round in 2021
Yido Co., Ltd. is an integrated management and project management company in Korea. The company engages in the operation and management of bridges, tunnels, major highways and main roads, ITS, airports, harbors, and railroads; management of highway rest areas and concession areas; and commercial real estate, corporate real estate, residential, and retail facilities. The company was founded in 2006 and is based in Seoul, South Korea.

Innometry

Post in 2020
Innometry Co., Ltd. manufactures and sells X-ray inspection systems in South Korea. Its products include X-ray battery testers, stacking manufacturing equipment, and other X-ray testers. The company is based in Anyang, South Korea.

POPS Worldwide

Venture Round in 2019
POPS Worldwide is the leading digital entertainment company in Southeast Asia. With over 4 billion monthly views of its music and entertainment content, POPS is the fastest growing digital entertainment media company with hundreds of artists, content creators and partners from broadcast television, publishing and production in the POPS Network. POPS also produces a wide variety of original content for its industry-leading owned and operated channels like POPS Music, POPS Kids, POPS TV, Beauty Me, HerVoice and CoolTV that target highly sought after demographics: teens, kids, women and men.

Working House

Private Equity Round in 2017
Working House is an online marketplace that offers food and beverage products.

Happycall

Private Equity Round in 2016
Happycall delivers the best quality and sincerity, so that cooking for the precious family can be a happy and pleasant time experience Happycall developed the first double-sided frying pan to the world, and has since been making efforts to develop products with unique functions and provide the highest quality, such as Diamond Frying Pan, IH Vacuum Pot, etc Happycall practices honest management that strictly complies with the principle and production process that no product will be sold before having enough confidence in the quality through continuous R&D by the internal R&D center.

TCM Biosciences

Private Equity Round in 2016
TCM Biosciences Inc. researches, develops, and sells in-vitro diagnostics and reagents. It offers reagents, instruments, and systems, including liquid based cytology processors, cervical cancer HPV/STI self-collection kits, and STD self test kits for use in the collection, preparation, and examination of specimens taken and diagnosed outside the human body. The company also provides molecular diagnosis tools for the detection and analysis of diseases/infections, such as cancer risk evaluation, anti-aging Mitochondria activity analysis, respiratory pathogens, sexually transmitted infections, human Papillomavirus screening, tuberculosis, BRAF codeon V600E, ApoE genotyping, and avellino corneal dystrophy. TCM Biosciences Inc. was founded in 2009 and is based in Seongnam, South Korea. As of July 17, 2020, TCM Biosciences Inc. operates as a subsidiary of Next Bt Co., Ltd.

OSANG Healthcare

Private Equity Round in 2016
Osang Healthcare focuses on developing innovative diagnostic biosensors, primarily for blood glucose measurement. The company aims to make medical devices as accessible as household appliances, facilitating the easy monitoring of various diseases worldwide. Its product range includes blood glucose monitoring systems, HbA1c analyzers, cholesterol measuring systems, immune diagnostic devices, and molecular diagnostic devices. Operating in over 110 countries, Osang Healthcare aspires to lead in the research and development of diagnostic sensors for heart disease and cancer, as well as remote diagnosis systems, thereby enhancing disease management and patient care globally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.